{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:14:52Z","timestamp":1784808892865,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10741-019-09844-8","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T21:09:50Z","timestamp":1565730590000},"page":"823-831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer\u2014a network meta-analysis"],"prefix":"10.1007","volume":"25","author":[{"given":"Pingping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaosi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"9844_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129:837\u2013847","journal-title":"Circulation"},{"key":"9844_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1161\/STROKEAHA.117.016926","volume":"48","author":"TH Kim","year":"2017","unstructured":"Kim TH, Yang PS, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, Lip GYH (2017) CHA2DS2-VASc score (congestive heart failure, hypertension, age \u226575 [doubled], diabetes mellitus, prior stroke or transient ischemic attack [doubled], vascular disease, age 65-74, female) for stroke in Asian patients with atrial fibrillation: a Korean nationwide sample cohort study. Stroke 48:1524\u20131530","journal-title":"Stroke"},{"key":"9844_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/154099903768248249","volume":"12","author":"JT Lin","year":"2003","unstructured":"Lin JT (2003) Thromboembolic events in the cancer patient. J Women\u2019s Health 12:541\u2013551","journal-title":"J Women\u2019s Health"},{"key":"9844_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","volume":"34","author":"TM Suter","year":"2013","unstructured":"Suter TM, Ewer MS (2013) Cancer drugs and the heart: importance and management. Eur Heart J 34:1102\u20131111","journal-title":"Eur Heart J"},{"key":"9844_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","volume":"63","author":"D Farmakis","year":"2014","unstructured":"Farmakis D, Parissis J, Filippatos G (2014) Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol 63:945\u2013953","journal-title":"J Am Coll Cardiol"},{"key":"9844_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ijcard.2015.10.166","volume":"203","author":"YJ Lee","year":"2016","unstructured":"Lee YJ, Park JK, Uhm JS, Kim JY, Pak HN, Lee MH, Sung JH, Joung B (2016) Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy. Int J Cardiol 203:372\u2013378","journal-title":"Int J Cardiol"},{"key":"9844_CR7","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/gut.2005.080754","volume":"55","author":"A Lanas","year":"2006","unstructured":"Lanas A, Garc\u00eda-Rodr\u00edguez LA, Arroyo MT, Gomoll\u00f3n F, Feu F, Gonz\u00e1lez-P\u00e9rez A, Zapata E, B\u00e1stida G, Rodrigo L, Santolaria S, G\u00fcell M, de Argila CM, Quintero E, Borda F, Piqu\u00e9 JM (2006) Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 55:1731\u20131738","journal-title":"Gut"},{"key":"9844_CR8","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893\u20132962","journal-title":"Eur Heart J"},{"key":"9844_CR9","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1161\/CIRCULATIONAHA.112.115410","volume":"126","author":"F Dentali","year":"2012","unstructured":"Dentali F, Riva N, Crowther M, Turpie AG, Lip GY, Ageno W (2012) Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation 126:2381\u20132391","journal-title":"Circulation"},{"key":"9844_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2147\/DDDT.S45644","volume":"8","author":"H Mani","year":"2014","unstructured":"Mani H, Lindhoff-Last E (2014) New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness. Drug Des Devel Ther 8:789\u2013798","journal-title":"Drug Des Devel Ther"},{"key":"9844_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"issue":"14","key":"9844_CR12","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1182\/blood-2013-04-460162","volume":"122","author":"AY Lee","year":"2013","unstructured":"Lee AY, Peterson EA (2013) Treatment of cancer-associated thrombosis. Blood 122(14):2310\u20132317","journal-title":"Blood"},{"issue":"11","key":"9844_CR13","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.6004\/jnccn.2013.0165","volume":"11","author":"PC Hendrie","year":"2013","unstructured":"Hendrie PC, Garcia DA (2013) Are new oral anticoagulants ready for use in patients with cancer? J Natl Compr Cancer Netw 11(11):1446\u20131449","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"9844_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/bloodadvances.2017010694","volume":"2","author":"S Shah","year":"2018","unstructured":"Shah S, Norby FL, Datta YH, Lutsey PL, MacLehose RF, Chen LY, Alonso A (2018) Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Blood Adv 2(3):200\u2013209","journal-title":"Blood Adv"},{"key":"9844_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/ehjqcco\/qcy040","volume":"5","author":"ST Chen","year":"2019","unstructured":"Chen ST, Hellkamp AS, Becker RC, Berkowitz SD, Breithardt G, Fox KAA, Hacke W, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, Piccini JP, Singer DE, Patel MR, Melloni C (2019) Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF. Eur Heart J Qual Care Clin Outcomes 5:145\u2013152","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"9844_CR16","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/sim.1875","volume":"23","author":"G Lu","year":"2004","unstructured":"Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23:3105\u20133124","journal-title":"Stat Med"},{"key":"9844_CR17","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65\u2013W94","journal-title":"Ann Intern Med"},{"key":"9844_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149:315\u2013352","journal-title":"Chest"},{"key":"9844_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/europace\/eur126","volume":"13","author":"GY Lip","year":"2011","unstructured":"Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, Lane DA, Levi M, Marin F, Palareti G, Kirchhof P (2011) Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace 13:723\u2013746","journal-title":"Europace"},{"key":"9844_CR20","volume-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis","author":"W GA","year":"2012","unstructured":"GA W, Shea BOCD, Peterson JWV (2012) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Department of Epidemiology and Community Medicine, Ottawa"},{"key":"9844_CR21","unstructured":"JP Higgins, S Green (2019) Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0). Available at: https:\/\/training.cochrane.org\/handbook . Accessed 1 May 2019"},{"key":"9844_CR22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","volume":"7","author":"SP Brooks","year":"1998","unstructured":"Brooks SP, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7:434\u2013455","journal-title":"J Comput Graph Stat"},{"key":"9844_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64:163\u2013171","journal-title":"J Clin Epidemiol"},{"key":"9844_CR24","doi-asserted-by":"publisher","unstructured":"Yang P, Shen W, Chen X, Zhu D, Xu X, Wu T, Xu G, Wu Q (2019) Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials. Heart Fail Rev Apr 27. https:\/\/doi.org\/10.1007\/s10741-019-09790-5","DOI":"10.1007\/s10741-019-09790-5"},{"issue":"12","key":"9844_CR25","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.amjmed.2017.06.026","volume":"130","author":"C Melloni","year":"2017","unstructured":"Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, Hylek EM, Hanna M, Wallentin L, Gersh BJ, Douglas PS, Alexander JH, Lopes RD (2017) Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE trial. Am J Med 130(12):1440\u20131448","journal-title":"Am J Med"},{"issue":"16","key":"9844_CR26","doi-asserted-by":"publisher","first-page":"e008987","DOI":"10.1161\/JAHA.118.008987","volume":"7","author":"CL Fanola","year":"2018","unstructured":"Fanola CL, Ruff CT, Murphy SA, Jin J, Duggal A, Babilonia NA, Sritara P, Mercuri MF, Kamphuisen PW, Antman EM, Braunwald E, Giugliano RP (2018) Efficacy and safety of edoxaban in patients with active malignancy and atrial fibrillation: analysis of the ENGAGE AF - TIMI 48 trial. J Am Heart Assoc 7(16):e008987","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"9844_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4070\/kcj.2017.0328","volume":"48","author":"K Kim","year":"2018","unstructured":"Kim K, Lee YJ, Kim TH, Uhm JS, Pak HN, Lee MH, Joung B (2018) Effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with newly diagnosed cancer. Korean Circ J 48(5):406\u2013417","journal-title":"Korean Circ J"},{"key":"9844_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.thromres.2017.05.006","volume":"155","author":"T Fitzpatrick","year":"2017","unstructured":"Fitzpatrick T, Carrier M, Le Gal G (2017) Cancer, atrial fibrillation, and stroke. Thromb Res 155:101\u2013105","journal-title":"Thromb Res"},{"key":"9844_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2017.03.132","volume":"240","author":"B Mery","year":"2017","unstructured":"Mery B, Guichard JB, Guy JB, Vallard A, Barthelemy JC, Da Costa A, Magn\u00e9 N, Bertoletti L (2017) Atrial fibrillation in cancer patients: hindsight, insight and foresight. Int J Cardiol 240:196\u2013202","journal-title":"Int J Cardiol"},{"issue":"9","key":"9844_CR30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/2047487318766942","volume":"25","author":"X Yao","year":"2018","unstructured":"Yao X, Noseworthy PA (2018) To teach an old dog new tricks: the limits of CHA2DS2-VASc in patients with atrial fibrillation and cancer. Eur J Prev Cardiol 25(9):994\u2013995","journal-title":"Eur J Prev Cardiol"},{"issue":"9526","key":"9844_CR31","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"S Connolly","year":"2006","unstructured":"ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367(9526):1903\u20131912","journal-title":"Lancet"},{"key":"9844_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3816\/CCC.2001.n.019","volume":"1","author":"MS Copur","year":"2001","unstructured":"Copur MS, Ledakis P, Bolton M, Morse AK, Werner T, Norvell M, Muhvic J, Chu E (2001) An adverse interaction between warfarin and capecitabine: a case report and review of the literature. Clin Colorectal Cancer 1:182\u2013184","journal-title":"Clin Colorectal Cancer"},{"key":"9844_CR33","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","volume":"61","author":"JD Wessler","year":"2013","unstructured":"Wessler JD, Grip LT, Mendell J, Giugliano RP (2013) The P-glycoprotein transport system and cardiovascular drugs. J Am Coll Cardiol 61:2495\u20132502","journal-title":"J Am Coll Cardiol"},{"issue":"9921","key":"9844_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet 383(9921):955\u2013962","journal-title":"Lancet"},{"key":"9844_CR35","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/j.hrthm.2019.01.024","volume":"16","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Field ME, Chen LY, Furie KL, Cigarroa JE, Heidenreich PA, Cleveland JC Jr, Murray KT, Ellinor PT, Shea JB, Ezekowitz MD, Tracy CM, Yancy CW (2019) 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 16:e66\u2013e93. https:\/\/doi.org\/10.1016\/j.hrthm.2019.01.024","journal-title":"Heart Rhythm"},{"key":"9844_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.beha.2008.12.009","volume":"22","author":"A Falanga","year":"2009","unstructured":"Falanga A, Panova-Noeva M, Russo L (2009) Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol 22:49\u201360","journal-title":"Best Pract Res Clin Haematol"},{"key":"9844_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1538-7836.2012.04693.x","volume":"10","author":"MN Levine","year":"2012","unstructured":"Levine MN, Gu C, Liebman HA, Escalante CP, Solymoss S, Deitchman D, Ramirez L, Julian J (2012) A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. J Thromb Haemost 10:807\u2013814","journal-title":"J Thromb Haemost"},{"key":"9844_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.thromres.2018.08.023","volume":"170","author":"MC Vedovati","year":"2018","unstructured":"Vedovati MC, Giustozzi M, Bonitta G, Agnelli G, Becattini C (2018) Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: a network meta-analysis. Thromb Res 170:175\u2013180","journal-title":"Thromb Res"},{"issue":"2","key":"9844_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0038-1661386","volume":"45","author":"V Russo","year":"2019","unstructured":"Russo V, Bottino R, Rago A, Micco PD, D\u2019Onofrio A, Liccardo B, Golino P, Nigro G (2019) Atrial fibrillation and malignancy: the clinical performance of non-vitamin K oral anticoagulants-a systematic review. Semin Thromb Hemost 45(2):205\u2013214","journal-title":"Semin Thromb Hemost"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09844-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09844-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09844-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T23:59:28Z","timestamp":1721606368000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09844-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9844"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09844-8","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"13 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}